Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CASP1 | P29466 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.59 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | LTA4H | P09960 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.57 |
| ▸ | RARB | P10826 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11258595 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL10427931 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL3058202 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL19491273 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL3051144 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL728423 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL9665213 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL3056357 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL14546295 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 | |
| SCHEMBL30517271 | 1.00 | NR5A1 (0.67) | NR5A1MEN1KMT2ALMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4668705-A | Sebosuppressive preparations containing alkoxyaryl alkanols | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-05-26 | — | — | US | claimed |
| CN-116120251-B | Cyclic diacylhydrazone derivative and synthesis and application thereof | 沈阳药科大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-116120251-A | Cyclic diacylhydrazone derivative and synthesis and application thereof | 沈阳药科大学 | 2023-05-16 | — | — | CN | disclosed |
| US-7671033-B2 | Amphiphilic dendritic dipeptides and their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671033-B2 | Amphiphilic dendritic dipeptides and their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-03-02 | — | — | US | disclosed |
| WO-2006085974-A2 | AMPHIPHILIC DENDRITIC DIPEPTIDES & THEIR SELF-ASSEMBLY INTO HELICAL PORES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2006-08-17 | — | — | WO | disclosed |
| US-20060088499-A1 | Amphiphilic dendritic dipeptides & their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2006-04-27 | — | — | US | disclosed |
| EP-0664282-B1 | Biaryl phospholipase A2 inhibitors | BRISTOL MYERS SQUIBB CO (US) | 1997-10-22 | — | — | EP | disclosed |
| EP-0664282-A1 | Biaryl phospholipase A2 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-07-26 | — | — | EP | disclosed |
| US-5391817-A | Antiinflammatory agents | BRISTOL-MYERS SQUIBB (US) | 1995-02-21 | — | — | US | disclosed |
| EP-0299789-B1 | MESOMORPHIC COMPOUND HAVING ALKYL BETA-HYDROXYCARBOXYLATE AS CHIRAL GROUP AND LIQUID CRYSTAL COMPOSITION CONTAINING SAME | MITSUBISHI RAYON CO., LTD. (JP) | 1992-05-20 | — | — | EP | disclosed |
| EP-0140033-B1 | SEBOSUPPRESIVE COSMETIC COMPOSITION CONTAINING ALKOXYARYL ALKANOLS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1990-01-31 | — | — | EP | disclosed |
| EP-0299789-A1 | Mesomorphic compound having alkyl beta-hydroxycarboxylate as chiral group and liquid crystal composition containing same | MITSUBISHI RAYON CO., LTD. (JP) | 1989-01-18 | — | — | EP | disclosed |
| US-4668705-A | Sebosuppressive preparations containing alkoxyaryl alkanols | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-05-26 | — | — | US | disclosed |
| EP-0072556-B1 | ACARICIDE COMPOUNDS | Montedison S.p.A. (IT) | 1986-01-29 | — | — | EP | disclosed |
| EP-0140033-A2 | Sebosuppresive cosmetic composition containing alkoxyaryl alkanols | Henkel Kommanditgesellschaft auf Aktien (DE) | 1985-05-08 | — | — | EP | disclosed |
| EP-0072556-A1 | Acaricide compounds | Montedison S.p.A. (IT) | 1983-02-23 | — | — | EP | disclosed |
| US-4350822-A | Antilipidemicpara-[aryl(alkyl or alkenyl)amino]benzoic acid derivatives | AMERICAN CYANAMID COMPANY (US) | 1982-09-21 | — | — | US | disclosed |
| US-4185115-A | Antilipidemic para-[aryl(alkyl or alkenyl)amino]-benzoic acid derivatives | AMERICAN CYANAMID COMPANY (US) | 1980-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060088499-A1 | Amphiphilic dendritic dipeptides & their self-assembly into helical pores | DNPEP, VIP, APLNR | NR5A1 3991/4885MEN1 2301/4885KMT2A 4261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.